33.05
전일 마감가:
$32.16
열려 있는:
$32.01
하루 거래량:
2.89M
Relative Volume:
2.00
시가총액:
$2.60B
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-0.06%
1개월 성능:
-31.03%
6개월 성능:
-41.69%
1년 성능:
+0.00%
Hinge Health Inc Stock (HNGE) Company Profile
명칭
Hinge Health Inc
전화
415-689-8429
주소
455 MARKET STREET, SAN FRANCISCO
Compare HNGE vs VEEV, TEM, BTSG, HQY, DOCS
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
HNGE
Hinge Health Inc
|
33.05 | 2.53B | 0 | 0 | 0 | 0.00 |
|
VEEV
Veeva Systems Inc
|
186.99 | 30.35B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
55.88 | 10.16B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
BTSG
Brightspring Health Services Inc
|
39.34 | 7.17B | 11.99B | 24.18M | 234.31M | 0.2956 |
|
HQY
Healthequity Inc
|
78.35 | 6.77B | 1.15B | 96.70M | -161.99M | 1.09 |
|
DOCS
Doximity Inc
|
27.24 | 5.08B | 550.17M | 201.35M | 232.07M | 1.00 |
Hinge Health Inc Stock (HNGE) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-09 | 개시 | Wells Fargo | Overweight |
| 2025-09-05 | 개시 | Robert W. Baird | Neutral |
| 2025-07-14 | 개시 | Citizens JMP | Mkt Outperform |
| 2025-06-16 | 개시 | Barclays | Overweight |
| 2025-06-16 | 개시 | BofA Securities | Buy |
| 2025-06-16 | 개시 | Canaccord Genuity | Buy |
| 2025-06-16 | 개시 | Evercore ISI | Outperform |
| 2025-06-16 | 개시 | KeyBanc Capital Markets | Overweight |
| 2025-06-16 | 개시 | Morgan Stanley | Overweight |
| 2025-06-16 | 개시 | Needham | Buy |
| 2025-06-16 | 개시 | Piper Sandler | Overweight |
| 2025-06-16 | 개시 | RBC Capital Mkts | Outperform |
| 2025-06-16 | 개시 | Raymond James | Outperform |
| 2025-06-16 | 개시 | Stifel | Buy |
| 2025-06-16 | 개시 | Truist | Buy |
| 2025-06-16 | 개시 | William Blair | Outperform |
모두보기
Hinge Health Inc 주식(HNGE)의 최신 뉴스
Hinge Health Reports Strong Q4 2025 Earnings with 46% Revenue Growth - Intellectia AI
Hinge Health reports fourth quarter and full year 2025 financial results - The National Law Review
Hinge Health Q4 2025 slides: 46% revenue growth, margins expand amid AI push - Investing.com
Earnings call transcript: Hinge Health Q4 2025 delivers strong earnings beat By Investing.com - Investing.com India
Hinge Health (NYSE:HNGE) Posts Quarterly Earnings Results - MarketBeat
Why Hinge Health, Inc. Class A Shares Are Sinking - TipRanks
Hinge Health soars as Q4 earnings triple estimates, outlook tops consensus - Investing.com India
(HNGE) Hinge Health Expects Full Year 2026 Revenue Range $732M$742M, vs. FactSet Est of $702.9M - marketscreener.com
Hinge Health Posts Record 2025 Results With Strong Profitability - TipRanks
(HNGE) Hinge Health, Inc. Expects Q1 Revenue Range $171.0M$173.0M - marketscreener.com
Hinge Health, Inc. options imply 9.7% move in share price post-earnings - TipRanks
Hinge Health earnings on deck as profitability test looms By Investing.com - Investing.com Canada
Hinge Health Inc (HNGE) Trading 2.57% Higher on Feb 10 - GuruFocus
Analysts Are Bullish on Top Healthcare Stocks: Hinge Health, Inc. Class A (HNGE), Centene (CNC) - The Globe and Mail
Hinge Health (NYSE:HNGE) Sets New 52-Week LowShould You Sell? - MarketBeat
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
Jim Cramer Shed Light on These 19 Stocks Recently - Insider Monkey
Hinge Health (NYSE:HNGE) Sets New 1-Year LowHere's Why - MarketBeat
Jim Cramer Says Hinge Health Is “Going to Be One of the Better Stocks We’ve Seen in the Healthcare Sector” - Yahoo Finance
Physio App Maker Hinge Health, Backers Seek $437 Million IPO - MSN
Citizens reiterates Market Outperform rating on Hinge Health stock By Investing.com - Investing.com UK
Citizens reiterates Market Outperform rating on Hinge Health stock - Investing.com
Why Hinge Health Shares Are Sliding Despite Optimism - TipRanks
Hinge Health Inc. (NYSE:HNGE) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Hinge Health Becomes Oversold (HNGE) - Nasdaq
Analyst Expectations For Hinge Health's Future - Benzinga
Analysts Conflicted on These Healthcare Names: Hinge Health, Inc. Class A (HNGE), Axsome Therapeutics (AXSM) and TG Therapeutics (TGTX) - The Globe and Mail
Freedom Capital Markets Initiates Coverage of Hinge Health (HNGE) with Buy Recommendation - Nasdaq
Canaccord Genuity reiterates Buy rating on Hinge Health stock ahead of earnings - Investing.com UK
Freedom Capital Markets initiates Buy on Hinge Health stock with $59 target - Investing.com
Canaccord Genuity reiterates Buy rating on Hinge Health stock ahead of earnings By Investing.com - Investing.com South Africa
Stifel reiterates Buy rating on Hinge Health stock citing MSK care gaps - Investing.com Nigeria
Stifel reiterates Buy rating on Hinge Health stock citing MSK care gaps By Investing.com - Investing.com South Africa
Hinge Health Inc (HNGE) Trading Down 3.2% on Jan 20 - GuruFocus
Will Hinge Health Inc. (HNGE) beat estimates again in its next earnings report? - MSN
Assessing Hinge Health (HNGE) Valuation As Shares Show Recent Uptick But Weak Broader Momentum - Yahoo Finance
Hinge Health’s 2026 State of Musculoskeletal Care Report reveals stark gaps in traditional care - Chartmill
Hinge Health (NYSE:HNGE) Trading Down 7.8%Here's What Happened - MarketBeat
Will Hinge Health Inc. (HNGE) Beat Estimates Again in Its Next Earnings Report? - Yahoo Finance
San Bernardino Sun - FinancialContent
Hinge Health to announce fourth quarter and full year 2025 financial results on February 10, 2026 - Business Wire
Hinge Health: Strong Usage Momentum, Conservative Growth Expectations, and Competitive Moat Support Buy Rating - TipRanks
Hinge Health (NYSE:HNGE) Upgraded at Wells Fargo & Company - MarketBeat
Piper Sandler lowers Hinge Health stock price target to $60 from $71 - Investing.com Canada
Piper Sandler lowers Hinge Health stock price target to $60 from $71 By Investing.com - Investing.com South Africa
Hinge Health, Inc. Class A Common Stock (NY: HNGE - FinancialContent
HNGE Stock Coverage Initiated by Wells Fargo with Overweight Rat - GuruFocus
Hinge Health stock initiated with Overweight rating by Wells Fargo - Investing.com Australia
Hinge Health Inc (HNGE) 재무 분석
Hinge Health Inc (HNGE)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):